Cadence Capital Management’s Psychemedics Corporation PMD Stock Holding History

Cadence Capital Management’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-67,274	Closed	-$1.12M	–	679
2015 Q1	$1.12M	Buy	67,274 +189	+0.3%	+$2.95K	0.07%	379
2014 Q4	$1.02M	Sell	67,085 -5,452	-8%	-$79.2K	0.06%	401
2014 Q3	$1.03M	Sell	72,537 -1,980	-3%	-$28.1K	0.05%	398
2014 Q2	$1.05M	Sell	74,517 -8,198	-10%	-$125K	0.05%	417
2014 Q1	$1.42M	Buy	82,715 +14,245	+21%	+$236K	0.06%	373
2013 Q4	$1.01M	Buy	68,470 +42,756	+166%	+$588K	0.04%	437
2013 Q3	$341K	Buy	+25,714	New	+$319K	0.01%	565

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

Cadence Capital Management's PMD Position: Q2 2015 in Review

Cadence Capital Management sold out of Psychemedics Corporation (PMD) in Q2 2015, closing a stake of 67,274 shares — an estimated $1.12M sold.

Cadence Capital Management first reported a position in PMD in Q3 2013 and held it in 7 quarters. The position peaked at $1.42M in Q1 2014. 38 funds tracked by Wall St. Rank hold PMD as of Q2 2015.

Cadence Capital Management reported no remaining Psychemedics Corporation position as of Q2 2015 after selling out during the quarter.
Cadence Capital Management sold 67,274 Psychemedics Corporation shares in Q2 2015, an estimated $1.12M.
Cadence Capital Management first reported a position in Psychemedics Corporation in Q3 2013 and held it in 7 quarters.
Cadence Capital Management's Psychemedics Corporation position peaked at $1.42M in Q1 2014.
38 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2015.

Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.